Tapewire

Nasdaq · USD

DRIO

DarioHealth Corp.

Export transactions ↓
Tapewire entity
7024
SEC CIK
0001533998
Parsed reports
352

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 24, 2026 Filed Sep 28, 2026 20:07 UTC GrantCommon stock 62,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111353 · tm2626098-4_4seq1.xml · nonDerivative · entry 1

PALUMBO JOHN R · CIK 0001251475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,500

F1 · date: The restricted share award shall vest on the second anniversary of the grant date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:07 UTC
STERN ADAM KDirector
GrantCommon Stock 28,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111351 · tm2626098-9_4seq1.xml · nonDerivative · entry 3

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,717

F4 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:06 UTC GrantCommon Stock 61,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111350 · tm2626098-3_4seq1.xml · nonDerivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,737

F1 · date: The restricted share award shall vest on the second anniversary of the grant date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:06 UTC
Shaked YoavDirector
GrantCommon Stock 54,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111349 · tm2626098-7_4seq1.xml · nonDerivative · entry 2

Shaked Yoav · CIK 0001744499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,582

F3 · date: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:06 UTC GrantCommon Stock 44,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111347 · tm2626098-2_4seq1.xml · nonDerivative · entry 1

Matheis Dennis · CIK 0001817012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,026

F1 · date: The restricted share award shall vest on the second anniversary of the grant date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:05 UTC
Raphael ErezDirector · Chief Executive Officer
GrantCommon Stock 297,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111343 · tm2626098-1_4seq1.xml · nonDerivative · entry 2

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 454,432

F3 · date: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:05 UTC
Karah HilaDirector
GrantCommon Stock 28,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111346 · tm2626098-5_4seq1.xml · nonDerivative · entry 1

Karah Hila · CIK 0001668116 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,965

F1 · date: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:06 UTC
Franco-Yehuda ChenChief Financial Officer
GrantCommon Stock 95,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-111348 · tm2626098-6_4seq1.xml · nonDerivative · entry 1

Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

F1 · date: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.

Read SEC document
July 23, 2026 Filed Jul 28, 2026 21:27 UTC PurchaseCommon Stock 14,430 $6.93 $99,999.90
Disclosure

SEC source: 0001104659-26-087626 · tm2621505-1_4seq1.xml · nonDerivative · entry 2

Matheis Dennis · CIK 0001817012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,026

F3 · date: The reported shares were acquired pursuant to a Securities Purchase Agreement with the issuer, dated July 22, 2026, at a purchase price of $6.93 per share.

Read SEC document
September 18, 2025 Filed Sep 28, 2026 20:07 UTC
STERN ADAM KDirector
ConversionSeries D-2 Preferred Stock · Derivative 100 $1,000.00 Strike: $1,000.00 $100,000.00
Disclosure

SEC source: 0001104659-26-111351 · tm2626098-9_4seq1.xml · derivative · entry 5

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By AKS Family Partners L.P.

Disclosed balance after: 0

Underlying: Common Stock · 8,435 shares

Expires 2025-09-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.underlying_shares: AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock.

Read SEC document
September 18, 2025 Filed Sep 28, 2026 20:07 UTC
STERN ADAM KDirector
ConversionSeries C Preferred Stock · Derivative 250 $1,000.00 Strike: $1,000.00 $250,000.00
Disclosure

SEC source: 0001104659-26-111351 · tm2626098-9_4seq1.xml · derivative · entry 4

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By AKS Family Partners L.P.

Disclosed balance after: 0

Underlying: Common Stock · 11,760 shares

Expires 2025-09-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.underlying_shares: AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis.

Read SEC document
September 18, 2025 Filed Sep 28, 2026 20:07 UTC
STERN ADAM KDirector
ConversionCommon Stock 8,435 $16.60 $140,021.00
Disclosure

SEC source: 0001104659-26-111351 · tm2626098-9_4seq1.xml · nonDerivative · entry 2

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By AKS Family Partners L.P.

Disclosed balance after: 26,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations.

F3 · shares: AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock.

F3 · price: AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock.

Read SEC document
September 18, 2025 Filed Sep 28, 2026 20:07 UTC
STERN ADAM KDirector
ConversionCommon Stock 11,760 $40.40 $475,104.00
Disclosure

SEC source: 0001104659-26-111351 · tm2626098-9_4seq1.xml · nonDerivative · entry 1

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By AKS Family Partners L.P.

Disclosed balance after: 17,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations.

F2 · shares: AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis.

F2 · price: AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 18:04 UTC
Nelson Steven CharlesPresident and CCO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090098 · tm2526001-10_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · President and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,750

F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:05 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-089996 · tm2526001-3_4seq1.xml · nonDerivative · entry 1

Matheis Dennis · CIK 0001817012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,631

F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 16:06 UTC
Karah HilaDirector
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-089997 · tm2526001-4_4seq1.xml · nonDerivative · entry 1

Karah Hila · CIK 0001668116 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,965

F1 · date: The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 16:08 UTC
Raphael ErezDirector · Chief Executive Officer
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090006 · tm2526001-7_4seq1.xml · nonDerivative · entry 1

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,853

F1 · date: The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 16:20 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090019 · tm2526001-9_4seq1.xml · nonDerivative · entry 1

Leisure Lawrence B. · CIK 0001642824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 22:03 UTC
STERN ADAM KDirector
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090097 · tm2526001-2_4seq1.xml · nonDerivative · entry 1

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,717

F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:06 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090002 · tm2526001-5_4seq1.xml · nonDerivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,737

F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:08 UTC
Shaked YoavDirector
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090007 · tm2526001-8_4seq1.xml · nonDerivative · entry 1

Shaked Yoav · CIK 0001744499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,810

F1 · date: The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:07 UTC
Franco-Yehuda ChenChief Financial Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-090004 · tm2526001-6_4seq1.xml · nonDerivative · entry 1

Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · date: The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

Read SEC document
August 27, 2025 Filed Aug 27, 2025 16:30 UTC
Nelson Steven CharlesPresident and CCO
PurchaseCommon Stock 40,000 $0.53 $21,200.00
Disclosure

SEC source: 0001104659-25-084035 · tm2524544-1_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · President and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,000

Read SEC document
May 15, 2025 Filed May 15, 2025 20:02 UTC
Franco-Yehuda ChenChief Financial Officer
GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-049388 · tm2515033-2_4seq1.xml · nonDerivative · entry 1

Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

F1 · shares: The restricted shares vest over three years, with one third of such shares vesting on April 27, 2026, and the remaining shares vesting in equal quarterly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date The vesting period shall immediately end, and all shares shall immediately vest, in the event of a change in control of the Registrant (as defined in the Registrant's 2020 Equity incentive Plan, as amended).

Read SEC document
February 24, 2025 Filed Feb 25, 2025 16:02 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-016923 · tm257590-1_4seq1.xml · nonDerivative · entry 1

KAPLAN JON H. · CIK 0001751699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,574

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:04 UTC
STERN ADAM KDirector
PurchaseSeries D-2 Preferred Stock · Derivative 100 $1,000.00 Strike: $0.83 $100,000.00
Disclosure

SEC source: 0001104659-25-002530 · tm252765-1_4seq1.xml · derivative · entry 4

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · AKS Family Partners L.P.

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F1 · derivative.exercise_date: The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.

F1 · derivative.expiration_date: The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.

F1 · derivative.underlying_shares: The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.

Read SEC document
November 12, 2024 Filed Nov 14, 2024 16:15 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.91 $4,546.00
Disclosure

SEC source: 0001104659-24-118926 · tm2428408-1_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Read SEC document
September 11, 2024 Filed Sep 12, 2024 16:37 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.80 $4,022.50
Disclosure

SEC source: 0001104659-24-099353 · tm2423915-1_4seq1.xml · nonDerivative · entry 2

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Read SEC document
September 10, 2024 Filed Sep 12, 2024 16:37 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.84 $4,221.00
Disclosure

SEC source: 0001104659-24-099353 · tm2423915-1_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Read SEC document
September 09, 2024 Filed Sep 10, 2024 06:00 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.80 $4,000.00
Disclosure

SEC source: 0001104659-24-098312 · tm2423624-1_4seq1.xml · nonDerivative · entry 3

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Read SEC document
September 06, 2024 Filed Sep 10, 2024 06:00 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.84 $4,200.50
Disclosure

SEC source: 0001104659-24-098312 · tm2423624-1_4seq1.xml · nonDerivative · entry 2

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Read SEC document
September 05, 2024 Filed Sep 10, 2024 06:00 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.82 $4,091.00
Disclosure

SEC source: 0001104659-24-098312 · tm2423624-1_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Read SEC document
August 27, 2024 Filed Aug 28, 2024 18:12 UTC
Raphael ErezDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $0.88 $4,400.00
Disclosure

SEC source: 0001104659-24-094109 · tm2422950-1_4seq1.xml · nonDerivative · entry 1

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,937,059

Read SEC document
August 23, 2024 Filed Aug 23, 2024 16:05 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.95 $4,749.50
Disclosure

SEC source: 0001104659-24-092420 · tm2422584-2_4seq1.xml · nonDerivative · entry 3

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Read SEC document
August 22, 2024 Filed Aug 23, 2024 16:05 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.95 $4,725.00
Disclosure

SEC source: 0001104659-24-092420 · tm2422584-2_4seq1.xml · nonDerivative · entry 2

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
August 21, 2024 Filed Aug 23, 2024 16:05 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.93 $4,672.50
Disclosure

SEC source: 0001104659-24-092420 · tm2422584-2_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
August 21, 2024 Filed Aug 23, 2024 16:05 UTC
Raphael ErezDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $0.95 $4,750.00
Disclosure

SEC source: 0001104659-24-092417 · tm2422584-1_4seq1.xml · nonDerivative · entry 2

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,932,059

Read SEC document
August 20, 2024 Filed Aug 20, 2024 16:01 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.94 $4,684.50
Disclosure

SEC source: 0001104659-24-091267 · tm2422157-2_4seq1.xml · nonDerivative · entry 2

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
August 20, 2024 Filed Aug 23, 2024 16:05 UTC
Raphael ErezDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $0.93 $4,650.00
Disclosure

SEC source: 0001104659-24-092417 · tm2422584-1_4seq1.xml · nonDerivative · entry 1

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,927,059

Read SEC document
August 19, 2024 Filed Aug 20, 2024 16:01 UTC
Nelson Steven CharlesChief Commercial Officer
PurchaseCommon Stock 5,000 $0.92 $4,598.50
Disclosure

SEC source: 0001104659-24-091267 · tm2422157-2_4seq1.xml · nonDerivative · entry 1

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
August 19, 2024 Filed Aug 20, 2024 16:01 UTC
Raphael ErezDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $0.90 $4,500.00
Disclosure

SEC source: 0001104659-24-091264 · tm2422157-1_4seq1.xml · nonDerivative · entry 3

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,922,059

Read SEC document
August 16, 2024 Filed Aug 20, 2024 16:01 UTC
Raphael ErezDirector · Chief Executive Officer
PurchaseCommon Stock 3,000 $0.90 $2,700.00
Disclosure

SEC source: 0001104659-24-091264 · tm2422157-1_4seq1.xml · nonDerivative · entry 2

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,917,059

Read SEC document
August 16, 2024 Filed Aug 20, 2024 16:01 UTC
Raphael ErezDirector · Chief Executive Officer
PurchaseCommon Stock 2,000 $0.89 $1,780.00
Disclosure

SEC source: 0001104659-24-091264 · tm2422157-1_4seq1.xml · nonDerivative · entry 1

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,914,059

Read SEC document
August 12, 2024 Filed Sep 28, 2026 20:06 UTC
Shaked YoavDirector
ConversionSeries B-2 Preferred Stock · Derivative 40 $1,000.00 Strike: $1,000.00 $40,000.00
Disclosure

SEC source: 0001104659-26-111349 · tm2626098-7_4seq1.xml · derivative · entry 4

Shaked Yoav · CIK 0001744499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 772 shares

Expires 2024-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2024 Filed Sep 28, 2026 20:06 UTC
Shaked YoavDirector
ConversionCommon Stock 772 $19.10 $14,745.20
Disclosure

SEC source: 0001104659-26-111349 · tm2626098-7_4seq1.xml · nonDerivative · entry 1

Shaked Yoav · CIK 0001744499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.

F2 · shares: The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion.

F2 · price: The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion.

F2 · balance_after: The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion.

Read SEC document
August 12, 2024 Filed Sep 28, 2026 20:05 UTC
Raphael ErezDirector · Chief Executive Officer
ConversionSeries B-2 Preferred Stock · Derivative 30 $1,000.00 Strike: $1,000.00 $30,000.00
Disclosure

SEC source: 0001104659-26-111343 · tm2626098-1_4seq1.xml · derivative · entry 4

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 579 shares

Expires 2024-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2024 Filed Sep 28, 2026 20:05 UTC
Raphael ErezDirector · Chief Executive Officer
ConversionCommon Stock 579 $19.10 $11,058.90
Disclosure

SEC source: 0001104659-26-111343 · tm2626098-1_4seq1.xml · nonDerivative · entry 1

Raphael Erez · CIK 0001668046 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.

F2 · shares: The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion.

F2 · price: The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion.

F2 · balance_after: The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion.

Read SEC document
August 12, 2024 Filed Jul 28, 2026 21:27 UTC ConversionSeries B-2 Preferred Stock · Derivative 50 $1,000.00 Strike: $1,000.00 $50,000.00
Disclosure

SEC source: 0001104659-26-087626 · tm2621505-1_4seq1.xml · derivative · entry 3

Matheis Dennis · CIK 0001817012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 965 shares

Expires 2024-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2024 Filed Jul 28, 2026 21:27 UTC ConversionCommon Stock 965 $19.10 $18,431.50
Disclosure

SEC source: 0001104659-26-087626 · tm2621505-1_4seq1.xml · nonDerivative · entry 1

Matheis Dennis · CIK 0001817012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,596

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.

F2 · shares: The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion.

F2 · price: The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion.

F2 · balance_after: The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 16:02 UTC
Nelson Steven CharlesChief Commercial Officer
GrantStock Option (right to buy) · Derivative 1,200,000 $0.00 Strike: $1.35 $0.00
Disclosure

SEC source: 0001104659-24-069618 · tm2416654-2_4seq1.xml · derivative · entry 3

Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,350,000

Underlying: Common Stock · 1,350,000 shares

Expires 2034-06-05

F3 · derivative.exercise_date: The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027.

F3 · derivative.expiration_date: The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.